FL S1404

Requires cancer clinical trial programs to inform prospective patients before enrollment that reimbursement for travel and ancillary costs is available based on financial need and that caregivers are also eligible for reimbursement.

Authorizes corporations, individuals, foundations, health care providers, and other stakeholders to provide financial support through third-party nonprofit corporations and public charities to reimburse ancillary costs and travel expenses for patient subjects and caregivers in cancer clinical trials.

Specifies that reimbursement offers for travel and ancillary expenses are not considered inducements for participation if they are not coercive or exerting undue influence on prospective participants.

Requires third-party nonprofit corporations and public charities offering reimbursement programs to secure informed consent from patient subjects regarding financial eligibility guidelines and reimbursement processes before trial participation begins.

Directs the Department of Health to review and approve reimbursement programs that fairly recruit patients and are consistent with federal regulations and guidance, and authorizes the department to adopt implementing rules.